Company profile
Sal Scientific Limited
Sal Scientific Limited is a UK company with status active founded in 2013 based in South West England.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQ0NDk0MTQxNWFkaXF6a2N4
Published 26 Nov 2024 02:51
Gazette Filings Brought Up To Date
GazetteDISS40 | Transaction MzQzMjE2NjIzNWFkaXF6a2N4 | Paper/PDF filed
Published 18 Aug 2024 07:39
Legacy
Accounts PDF pendingPARENT_ACC | Transaction MzQzMjE2NjAxNWFkaXF6a2N4 | Paper/PDF filed
Published 16 Aug 2024 12:21
Change Account Reference Date Company Previous Shortened
Accounts Awaiting analysisAA01 | Transaction MzQzMjE4MTU3MWFkaXF6a2N4
Published 14 Aug 2024 17:52
Accounts With Accounts Type Audit Exemption Subsiduary
Accounts PDF pendingAA | Transaction MzQzMjE2NjE5MmFkaXF6a2N4 | Paper/PDF filed
Published 14 Aug 2024 13:59
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Development of a novel 3D microfluidic assay platform for the assessment of human stem-cell derived epithelial function.
1 Apr 2016 to 30 Sep 2018
We aim to develop a novel analytical platform for the assessment of stem cell-derived epithelial function. The platform integrates novel microfluidic technology with a 3D stem cell-derived tissue model and a range of analytical outputs and delivers more physiologically relevant data than current in vitro models – uncovering previously unseen responses to ...
Novel microfluidic assay platform for the assessment of stem cell-derived epithelial function.
1 Jun 2015 to 30 Sep 2015
We aim to develop a novel analytical platform for the assessment of epithelial function across a range of tissue types. The platform integrates microfluidic technology with a range of analytical outputs and delivers more physiologically relevant data than current in vitro models – uncovering previously unseen responses to environmental challenge. However,...